Why United Therapeutics (UTHR) Stock Is Up Today [Yahoo! Finance]
United Therapeutics Corporation (UTHR)
Last united therapeutics corporation earnings: 4/29 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.unither.com/investor-relations
Company Research
Source: Yahoo! Finance
announced its TETON-1 pivotal study of Tyvaso met its primary endpoint for the treatment of idiopathic pulmonary fibrosis, a type of lung disease. The study showed that its drug, nebulized Tyvaso, was superior to a placebo in improving lung function. Specifically, the treatment improved what is known as forced vital capacity (FVC), a key measure of lung health, by 130.1 mL over 52 weeks. In addition to improving FVC, the drug also reduced the risk of clinical worsening for patients. The positive results were consistent across all patient subgroups and did not raise new safety concerns. Is now the time to buy United Therapeutics? Access our full analysis report here, it's free What Is The Market Telling Us United Therapeutics's shares are not very volatile and have only had 9 moves greater than 5% over the last year. Moves this big are rare for United Therapeutics and indicate this news significantly impacted the market's perception of the business. The biggest move we wrote
Show less
Read more
Impact Snapshot
Event Time:
UTHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
UTHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
UTHR alerts
High impacting United Therapeutics Corporation news events
Weekly update
A roundup of the hottest topics
UTHR
News
- United Therapeutics (UTHR) had its price target raised by HC Wainwright from $600.00 to $660.00. They now have a "buy" rating on the stock.MarketBeat
- United Therapeutics (UTHR) had its price target raised by Wells Fargo & Company from $486.00 to $575.00. They now have an "equal weight" rating on the stock.MarketBeat
- United Therapeutics Gets Dual Target Hikes From BofA and Wells Fargo [Yahoo! Finance]Yahoo! Finance
- United Therapeutics (UTHR) had its price target raised by Bank of America Corporation from $569.00 to $626.00. They now have a "neutral" rating on the stock.MarketBeat
- United Therapeutics Stock Soars on Strong Phase 3 Lung Disease Results [Yahoo! Finance]Yahoo! Finance
UTHR
Earnings
- 10/29/25 - Beat
UTHR
Sec Filings
- 3/31/26 - Form 4
- 3/31/26 - Form 4
- 3/31/26 - Form 4
- UTHR's page on the SEC website